Helius Medical Technologies, Inc. (HSDT)
NCM · Common · CUSIP 42328V603
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HSDT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
42328V603 (prev. 42328V504 )
Market Cap
Micro Cap
Business: Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. Helius seeks to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself.
Notes: Dec. 31, 2020 -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today a 1-for-35 reverse split of its Class A common stock, par value $0.001 (“common stock”), effective at 5:00 pm Eastern time today. Beginning on January 4, 2021, the Company’s common stock will trade on The Nasdaq Capital Market and the Toronto Stock Exchange on a split adjusted basis.

Company Contact

CEO
Dane C. Andreeff
CFO
Jeffrey S. Mathiesen
Headquarters
642 Newtown Yardley Road, Suite 100, Newtown, PA 18940
Phone
215-944-6100 · Toll-Free 877-564-0008
Investor Relations
Jack Powell, Westwicke Partners · 443-213-0500 · investorrelations@heliusmedical.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »